DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity
- DOI
- 10.1136/jitc-2021-004322
- Published
- 2022-06
- Container
- Journal for ImmunoTherapy of Cancer
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/jitc-2021-004322,
title = {DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity},
author = {Alexander Muik and Homer C Adams and Friederike Gieseke and Isil Altintas and Kristina B Schoedel and Jordan M Blum and Bianca Sänger and Saskia M Burm and Eliana Stanganello and Dennis Verzijl and Vanessa M Spires and Fulvia Vascotto and Aras Toker and Juliane Quinkhardt and Mark Fereshteh and Mustafa Diken and David P E Satijn and Sebastian Kreiter and Tahamtan Ahmadi and Esther C W Breij and Özlem Türeci and Kate Sasser and Ugur Sahin and Maria Jure-Kunkel},
year = {2022},
journal = {Journal for ImmunoTherapy of Cancer},
doi = {10.1136/jitc-2021-004322},
url = {https://doi.org/10.1136/jitc-2021-004322}
}RIS
TY - JOUR TI - DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity AU - Alexander Muik AU - Homer C Adams AU - Friederike Gieseke AU - Isil Altintas AU - Kristina B Schoedel AU - Jordan M Blum AU - Bianca Sänger AU - Saskia M Burm AU - Eliana Stanganello AU - Dennis Verzijl AU - Vanessa M Spires AU - Fulvia Vascotto AU - Aras Toker AU - Juliane Quinkhardt AU - Mark Fereshteh AU - Mustafa Diken AU - David P E Satijn AU - Sebastian Kreiter AU - Tahamtan Ahmadi AU - Esther C W Breij AU - Özlem Türeci AU - Kate Sasser AU - Ugur Sahin AU - Maria Jure-Kunkel PY - 2022 JO - Journal for ImmunoTherapy of Cancer DO - 10.1136/jitc-2021-004322 UR - https://doi.org/10.1136/jitc-2021-004322 ER -
APA
Muik, A., Adams, H. C., Gieseke, F., Altintas, I., Schoedel, K. B., Blum, J. M., Sänger, B., Burm, S. M., Stanganello, E., Verzijl, D., Spires, V. M., Vascotto, F., Toker, A., Quinkhardt, J., Fereshteh, M., Diken, M., Satijn, D. P. E., Kreiter, S., Ahmadi, T., Breij, E. C. W., Türeci, Ö., Sasser, K., Sahin, U., & Jure-Kunkel, M. (2022). DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2021-004322
Source records
- crossref · retrieved 2026-09-26T08:35:49.940Z